Valuation check: CVS's profit margin is 2.62%, below the Healthcare sector average of 19.13%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
The latest profit margin for CVS is 2.62% as of September 2026. That compares with 0.12% in the prior-year period — up 2105.1% year over year. That is below the Healthcare sector average of 19.13%. Investors often review this figure alongside CVS Health's historical trend and sector peers before judging valuation or financial health.
Over the past year, CVS's profit margin moved from 0.12% to 2.62% — a 2105.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in CVS Health's valuation or profitability profile.
Against Healthcare companies, CVS currently prints 2.62% for profit margin, while the sector average sits near 19.13%. That is roughly 86.3% below the sector mean. Large gaps often invite a closer look at CVS Health's growth, margins, and balance sheet.
Profit Margin shows how effectively CVS Health converts resources into returns. At 2.62%, CVS may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 0.12% in the prior-year period — up 2105.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting CVS's profit margin (2.62%), review year-over-year change from 0.12%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.